DineshKhannaMD
Rheumatology • Ann Arbor, MIFrederick GL Huetwell Professor of Medicine, Director, Scleroderma Program, University of Michigan
Dr. Khanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
3rd Floor Taubman Center Recp A
Ann Arbor, MI 48105Phone+1 734-647-5900- Is this information wrong?
Summary
- I am board certified in rheumatology and direct the University of Michigan Scleroderma Program.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2000 - 2003
Wright State UniversityResidency, Internal Medicine, 1997 - 2000
Delhi University College of Medical SciencesClass of 1996
Certifications & Licensure
MI State Medical License 2011 - 2027
OH State Medical License 1999 - 2008- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Curcumin in Rheumatoid Arthritis Start of enrollment: 2010 Jan 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- Author Correction: Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.Zsuzsanna H McMahan, Subhash Kulkarni, Joan Chen, Jiande Z Chen, Ramnik J Xavier, P Jay Pasricha, Dinesh Khanna> ;Nature Reviews. Rheumatology. 2023 Mar 1
- 7 citationsA 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.Dinesh Khanna, Christopher P Denton, Daniel E Furst, Maureen D Mayes, Marco Matucci-Cerinic, Vanessa Smith, Dick de Vries, Paul Ford, Yasmina Bauer, Matthew J Randall,...> ;Arthritis & Rheumatology. 2023 Aug 1
- 8 citationsSystemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.Zsuzsanna H McMahan, Subhash Kulkarni, Joan Chen, Jiande Z Chen, Ramnik J Xavier, P Jay Pasricha, Dinesh Khanna> ;Nature Reviews. Rheumatology. 2023 Mar 1
- Join now to see all
Journal Articles
- ReplyDinesh Khanna, Elana J Bernstein, David J Lederer, Arthritis & Rheumatology
- Ongoing Clinical Trials and Treatment Options for Patients with Systemic Sclerosis–Associated Interstitial Lung DiseaseDonald P Tashkin, Dinesh Khanna, Rheumatology
- Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase II Randomised Controlled Trial (faSScinate)Dinesh Khanna, Daniel Eric Furst, Emergency Medicine Journal
Press Mentions
Arthritis Drug Shows Promise Against Autoimmune Disease SclerodermaOctober 11th, 2022- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- Two Steps Forward, One Step Back: Hunting for a Game-Changer in SclerodermaMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
